» Articles » PMID: 19005642

Phosphodiesterases PDE3 and PDE4 Jointly Control the Inotropic Effects but Not Chronotropic Effects of (-)-CGP12177 Despite PDE4-evoked Sinoatrial Bradycardia in Rat Atrium

Overview
Specialty Pharmacology
Date 2008 Nov 14
PMID 19005642
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Acting through a low-affinity site of the beta(1)-adrenoceptor (beta(1L)AR), CGP12177 causes sinoatrial tachycardia and positive inotropic effects in left atrium but not in the ventricle of the rat. However, inhibition of either PDE3 or PDE4 also uncovers positive inotropic effects of CGP12177 in ventricle, but whether these phosphodiesterases also control the atrial agonist effects of CGP12177 was unknown. We, therefore, investigated the effects of the PDE3-selective inhibitor cilostamide (300 nM) and PDE4 inhibitor rolipram (1 microM) on the (-)-CGP12177-evoked increases of sinoatrial beating rate and force of paced left atria of the rat. Rolipram (n = 8) increased basal sinoatrial rate by 27 +/- 5 bpm but cilostamide (n = 8) had no effect. The chronotropic potency of (-)-CGP12177 (-logEC(50)M = 7.5) was not changed by rolipram and cilostamide or their combination. (-)-CGP12177 increased left atrial force with intrinsic activity 0.25 compared to (-)-isoprenaline. Rolipram (n = 8) and cilostamide (n = 8) did not change basal force of left atria but concurrent rolipram + cilostamide (n = 8) increased force by 52 +/- 9% of the effect of 200 microM (-)-isoprenaline. Neither rolipram nor cilostamide affected the inotropic potency of (-)-CGP12177 (-logEC(50)M = 7.4) but concurrent rolipram + cilostamide caused potentiation (-logEC(50)M = 8.2) and converted (-)-CGP12177 into a full agonist compared to (-)-isoprenaline. Cyclic AMP appears to maintain sinoatrial rate and PDE4 elicits bradycardia through hydrolysis of cAMP in a compartment distinct from the beta(1L)AR-induced cAMP compartment through which (-)-CGP12177 causes tachycardia. In contrast to the (-)-CGP12177-evoked tachycardia, not controlled by PDE3 and PDE4, these isoenzymes jointly reduce (-)-CGP12177-evoked increases of left atrial contractility through beta(1L)AR.

Citing Articles

Dual Activation of Phosphodiesterase 3 and 4 Regulates Basal Cardiac Pacemaker Function and Beyond.

Vinogradova T, Lakatta E Int J Mol Sci. 2021; 22(16).

PMID: 34445119 PMC: 8395138. DOI: 10.3390/ijms22168414.


Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.

Vinogradova T, Sirenko S, Lukyanenko Y, Yang D, Tarasov K, Lyashkov A Circ Arrhythm Electrophysiol. 2018; 11(6):e005896.

PMID: 29880528 PMC: 6025775. DOI: 10.1161/CIRCEP.117.005896.


Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System.

Ercu M, Klussmann E J Cardiovasc Dev Dis. 2018; 5(1).

PMID: 29461511 PMC: 5872362. DOI: 10.3390/jcdd5010014.


Novel cilostamide analogs, phosphodiesterase 3 inhibitors, produce positive inotropic but differential lusitropic and chronotropic effects on isolated rat atria.

Hosseini A, Shafiee-Nick R, Sadeghian H, Parsaee H Iran J Basic Med Sci. 2017; 20(6):639-647.

PMID: 28868120 PMC: 5569452. DOI: 10.22038/IJBMS.2017.8831.


Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.

Knight W, Yan C Horm Metab Res. 2012; 44(10):766-75.

PMID: 22951903 PMC: 4114334. DOI: 10.1055/s-0032-1321870.


References
1.
Kaumann A, Molenaar P . The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology. Pharmacol Ther. 2008; 118(3):303-36. DOI: 10.1016/j.pharmthera.2008.03.009. View

2.
Kaumann A, Molenaar P . Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol. 1996; 118(8):2085-98. PMC: 1909870. DOI: 10.1111/j.1476-5381.1996.tb15648.x. View

3.
Bender A, Beavo J . Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 2006; 58(3):488-520. DOI: 10.1124/pr.58.3.5. View

4.
Younes A, Lyashkov A, Graham D, Sheydina A, Volkova M, Mitsak M . Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells. J Biol Chem. 2008; 283(21):14461-8. PMC: 2386925. DOI: 10.1074/jbc.M707540200. View

5.
Galindo-Tovar A, Kaumann A . Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors. Br J Pharmacol. 2007; 153(4):710-20. PMC: 2259196. DOI: 10.1038/sj.bjp.0707631. View